Shelter Pharma Ltd

Export order completion

• Completed manufacturing and dispatched export order for Foliman Tablets and Joemega Capsules to Sudan.
• Order value USD 139,200; dispatched amount equal to total with NIL balance.
• Customer is Taha Drugs and Chemicals Co. Ltd; products are nutraceutical tablets and capsules.
• Export destination: Sudan; destination market shows growing demand.
• All products manufactured under FDA-certified GMP and ISO standards.
• Exclusive orders from Sudan indicate expanding market and potential ₹50 crore revenue opportunity.

Export order completion

• Export order for Nutraceutical Tablets from Taha Drugs and Chemicals Co. Ltd completed and dispatched.
• Order value USD 144,000; fully settled.
• Destination country is Sudan; dispatch completed.
• Manufacturing status: Completed; Dispatch status: Completed.
• Customer: Taha Drugs and Chemicals Co. Ltd; Product: Nutraceutical Tablets.
• Order underscores growing international presence and commitment to prompt delivery.
• Balance value pending dispatch: NIL.

Product Launch

• New Ayurvedic herbal product SHELTIDIN DS - Cough Spray launched on 20 August 2026.
• Domestic market focus with potential international expansion in due course.
• In-house R&D developed the product; GMP per FDA and ISO.
• Available on reputed e-commerce platforms from 20 August 2026.
• Product targets fast throat relief for dry cough and irritation.

Export order update

• Export order from Genet International for veterinary feed supplements completed and dispatched to Bangladesh.
• Total value USD 12,285; payment settled in full.
• Manufacturing and dispatch statuses both completed; no balance due.
• Destination: Bangladesh; export order.

Export order update

• Export order from Taha Drugs & Chemicals Co. Ltd for All Vitamins Tablet completed.
• Order value USD 103,538 and fully settled.
• Manufacturing status: Completed.
• Dispatch status: Completed; Destination: Sudan.
• Value dispatched to date: USD 103,538; Balance pending: NIL.
• Customer: Taha Drugs & Chemicals Co. Ltd.

Appointment of Independent Director

• Type: Appointment of Ms. Vinita Shivraj Gadhvi as Additional Non-Executive Independent Director
• Effective date and tenure: 31 July 2026 for five consecutive years, subject to shareholders' approval
• Reason: Board approved appointment on Nomination and Remuneration Committee recommendation
• Profile: PhD in Healthcare Startup Ecosystem; MBA in Total Quality Management; 12+ years in pharma/healthcare
• Relationships: Not related to any Director or KMP
• Regulatory: Not debarred by SEBI or other authorities

Appointments

• Vinita Shivraj Gadhvi appointed as Additional Non-Executive Independent Director for five years from 31 July 2026.
• Term not liable to retire by rotation; shareholder approval required.
• DIN 09102407; independent criteria satisfied per applicable SEBI regulations.

CSR Committee Reconstitution

• CSR Committee reconstituted with 4 members: Pathan (Chairman), Vinita Gadhvi (Member), Sabugar (MD, Member), Idariya (Director, Member).
• Mustaqim Nisarahmed Sabugar remains Managing Director and member.
• Profile of Vinita Gadhvi provided in Annexure.

Order details

• Awarding entity: Genet International (international entity).
• Products: veterinary feed supplements including FEEDMIN BOLUS, REGULIN BOLUS, Lactocal Gel, BUTA-B BOLUS.
• Total value: USD 12,285 (no tax stated).
• Execution: international order, to be completed within mutually agreed timelines per PO schedule.
• Related party: promoter group has no interest; not conducted at arm's length.
• Impact: strengthens international presence and supports revenue growth.

Dematerialisation/rematerialisation status

• No requests for dematerialisation or rematerialisation received during the quarter ended 30 June 2026.
• Regulation not applicable as entire holding is in demat form.

Order details

• Awarding entity: Al-Saqr Agro
• Scope: supply of veterinary feed supplements
• Products include Multina Liquid 1L, Multina Liquid 3L, Super Vitamas 20kg
• Order value: USD 27,664; CNF terms
• Entity is international
• Delivery time: 2 months from payment
• Payment terms: 100% advance; prices CNF
• Promoter group has no interest; arm's length
• Execution per PO timelines and shipment schedule
• Impact: strengthens international presence and revenue growth